Total Payments
$8,086
2024 Payments
$1,873
Companies
27
Transactions
506
Medicare Patients
1,305
Medicare Billing
$104,842
Payment Breakdown by Category
Food & Beverage$7,920 (97.9%)
Education$166.00 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,920 | 504 | 97.9% |
| Education | $166.00 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,396 | 153 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,051 | 147 | $0 (2024) |
| Janssen Biotech, Inc. | $667.40 | 40 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $650.22 | 35 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $453.06 | 29 | $0 (2024) |
| QOL Medical, LLC | $309.01 | 17 | $0 (2024) |
| Gilead Sciences, Inc. | $207.20 | 9 | $0 (2024) |
| PFIZER INC. | $167.17 | 9 | $0 (2024) |
| Braintree Laboratories, Inc. | $160.34 | 9 | $0 (2023) |
| Intercept Pharmaceuticals, Inc. | $153.06 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,873 | 103 | ABBVIE INC. ($626.33) |
| 2023 | $1,420 | 90 | ABBVIE INC. ($517.79) |
| 2022 | $2,241 | 150 | ABBVIE INC. ($637.50) |
| 2021 | $2,552 | 163 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($759.95) |
All Payment Transactions
506 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: VIROLOGY | ||||||
| 11/26/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $22.89 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/20/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| Category: GI | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: Gastroenterology | ||||||
| 11/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.07 | General |
| Category: GI | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: VIROLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Gastroenterology | ||||||
| 10/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Immunology | ||||||
| 10/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/04/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 332 | 422 | $89,908 | $30,541 |
| 2022 | 4 | 382 | 471 | $95,815 | $32,833 |
| 2021 | 7 | 361 | 450 | $82,649 | $30,780 |
| 2020 | 7 | 230 | 252 | $36,524 | $10,688 |
Total Patients
1,305
Total Services
1,595
Medicare Billing
$104,842
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 208 | 288 | $61,056 | $21,438 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $16,983 | $4,823 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 83 | $11,869 | $4,280 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 202 | 270 | $57,240 | $19,771 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 122 | 143 | $20,449 | $7,565 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $15,651 | $4,712 | 30.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,475 | $785.61 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 152 | 205 | $43,460 | $16,909 | 38.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 117 | $16,731 | $6,218 | 37.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 29 | 29 | $9,657 | $3,076 | 31.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 27 | 32 | $4,576 | $1,824 | 39.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $3,825 | $1,158 | 30.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 27 | 32 | $2,816 | $1,041 | 37.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 16 | 18 | $1,584 | $553.72 | 35.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 80 | 93 | $13,299 | $3,905 | 29.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 38 | 42 | $8,904 | $2,322 | 26.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 25 | 27 | $3,861 | $1,273 | 33.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 36 | 38 | $3,344 | $977.17 | 29.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 12 | 12 | $2,700 | $841.74 | 31.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 25 | 26 | $2,288 | $763.10 | 33.4% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 14 | 14 | $2,128 | $605.56 | 28.5% |
About Amy Nydam, APRN
Amy Nydam, APRN is a Family healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2017. The National Provider Identifier (NPI) number assigned to this provider is 1477070852.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Nydam, APRN has received a total of $8,086 in payments from pharmaceutical and medical device companies, with $1,873 received in 2024. These payments were reported across 506 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($7,920).
As a Medicare-enrolled provider, Nydam has provided services to 1,305 Medicare beneficiaries, totaling 1,595 services with total Medicare billing of $104,842. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location Lexington, KY
- Active Since 08/25/2017
- Last Updated 08/13/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1477070852
Products in Payments
- XIFAXAN (Drug) $1,291
- TRULANCE (Drug) $680.72
- LINZESS (Drug) $655.44
- RINVOQ (Biological) $577.40
- ENTYVIO (Biological) $528.95
- STELARA (Biological) $487.77
- HUMIRA (Biological) $456.00
- Linzess (Drug) $453.06
- SKYRIZI (Biological) $318.34
- SUCRAID (Drug) $271.55
- CREON (Drug) $245.53
- REMICADE (Biological) $179.63
- XELJANZ (Drug) $167.17
- SUTAB (Drug) $160.34
- OCALIVA (Drug) $153.06
- DIFICID (Drug) $116.79
- MOTEGRITY (Drug) $102.90
- ZENPEP (Drug) $97.48
- Talicia (Drug) $85.98
- ZEPOSIA (Drug) $81.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lexington
Alisha Clemons, Aprn, APRN
Family — Payments: $38,192
Family $38,192
Rose Pierson, Arnp, ARNP
Family — Payments: $12,246
Family $12,246
Lauren Maupin, Arnp, Fnp-C, ARNP, FNP-C
Family — Payments: $11,985
Family $11,985
Laura Travis, Aprn, APRN
Family — Payments: $10,435
Family $10,435
Michael Thorarinson, Fnp-Bc, FNP-BC
Family — Payments: $10,409
Family $10,409
Rhiannon Black, Aprn, APRN
Family — Payments: $9,756
Family $9,756